Melatonin inhibits the proliferation of breast cancer cells induced by bisphenol A via targeting estrogen receptor-related pathways.

Tianjiao WangBowen LiuYanan GuanMiaomiao GongWeiying ZhangJinjin PanYanan LiuRui LiangYuhui YuanLihong Ye

Published in: Thoracic cancer (2018)

Conclusions: Therefore, these results demonstrated that melatonin could abrogate BPA-induced proliferation of BC cells. Therapeutically, melatonin could be regarded as a potential medication for BPA-associated BC.

Keyphrases

estrogen receptor
signaling pathway
breast cancer cells
induced apoptosis
cell cycle arrest
high glucose
healthcare
diabetic rats
drug induced
emergency department
cancer therapy
cell death
pi k akt
adverse drug